Now available AVGEMSI™

AVGEMSI™ (gemcitabine) injection, for intravenous use, is a nucleoside metabolic inhibitor indicated:

• in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.
• in combination with paclitaxel, for first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.
• in combination with cisplatin, for the treatment of non-small cell lung cancer.
• as a single agent for the treatment of pancreatic cancer.
  
  

Please see full prescribing information here.